Yet, we were unable to confirm previously described risk factors—presence of ischemia,2 peripheral arterial disease, and higher C-reactive protein on admission.18 This may be related to both clinical and methodologic heterogeneity, notable in DFO,26 which limits direct comparison between study findings. The gene discussed is CRP; the disease is peripheral arterial disease.